27 research outputs found
Protein Tyrosine Phosphatase Activity in Insulin-Resistant Rodent Psammomys Obesus
Phosphotyrosine phosphatase (PTPase) activity and its regulation
by overnight food deprivation were studied in Psammomys
obesus (sand rat), a gerbil model of insulin resistance and nutritionally
induced diabetes mellitus. PTPase activity was measured
using a phosphopeptide substrate containing a sequence identical
to that of the major site of insulin receptor (IR) β-subunit autophosphorylation.
The PTPase activity in membrane fractions was 3.5-,
8.3-, and 5.9-fold lower in liver, fat, and skeletal muscle, respectively,
compared with corresponding tissues of albino rat.Western
blotting of tissue membrane fractions in Psammomys showed lower
PTPase and IR than in albino rats. The density of PTPase transmembrane
protein band was 5.5-fold lower in liver and 12-fold
lower in adipose tissue. Leukocyte antigen receptor (LAR) and IR
were determined by specific immunoblotting and protein bands
densitometry and were also found to be 6.3-fold lower in the liver
and 22-fold lower in the adipose tissue in the hepatic membrane
fractions. Liver cytosolic PTPase activity after an overnight food
deprivation in the nondiabetic Psammomys rose 3.7-fold compared
with postprandial PTPase activity, but it did not change significantly
in diabetic fasted animals. Similar fasting-related changes
were detected in the activity of PTPase derived from membrane
fraction. In conclusion, the above data demonstrate that despite
the insulin resistance, Psammomys is characterized by low level of
PTPase activities in membrane and cytosolic fractions in all 3 major insulin responsive tissues, as well as in liver. PTPase activity does
not rise in activity as a result of insulin resistance and nutritionally
induced diabetes
A high oleic sunflower oil fatty acid esters of plant sterols mixed with dietary diacylglycerol reduces plasma insulin and body fat accumulation in Psammomys obesus
<p>Abstract</p> <p>Background</p> <p>Metabolic syndrome is associated with subsequent development of cardiovascular diseases and type 2 diabetes. It is characterized by reduced response to insulin, central obesity, and dyslipidemia. Intake of plant sterols (PS) has been shown to confer a healthier lipid profile and ameliorate cardiovascular disease risk factors in experimental animals and humans. In this study we used an animal model of type 2 diabetes to assess the effects of a preparation of PS esterified to high oleic sunflower oil fatty acids mixed with dietary diacylglycerol (PS-HOSO) on diabetic related metabolic parameters. <it>Psammomys obesus </it>(<it>P. obesus</it>) were fed high energy (HE) diet supplemented by either PS-HOSO or control oil. Following 4.5 weeks of intervention, animals were divided into fasting and non-fasting modes prior to outcome measurements. Glucose and insulin levels as well as blood lipid profile, body weight, and fat accumulation were evaluated in fasting and non-fasting modes.</p> <p>Results</p> <p><it>P. obesus </it>fed with a HE diet displayed a characteristic heterogeneity in their blood glucose and insulin levels with a subset group displaying type 2 diabetes symptoms. PS-HOSO treatment significantly reduced total cholesterol (24%, <it>P </it>< 0.001) and non-HDL cholesterol (34%, <it>P </it>< 0.01) compared to the control diet. Among fasting animals, body weight at end point and epididymal fat-to-liver weight ratio were significantly (<it>P </it>< 0.05 each) reduced (7% and 16%, respectively) compared to controls. Interestingly, fasting blood glucose levels were similar between groups, whereas plasma insulin level at end point was 44% lower in the PS-HOSO group compared to control group (<it>P </it>< 0.0001)</p> <p>Conclusion</p> <p>PS-HOSO supplementation to diabetes-prone gerbils counteracts the increase in body weight and epididymal fat accumulation, and also results in a drop in circulating insulin levels. These effects are pointing out that PS-HOSO may serve as a functional ingredient for metabolic syndrome or diabetic sufferers, which not only influences body weight, but also prevents or reverses insulin resistance and hyperlipidemia.</p
Protein Tyrosine Phosphatase 1B is Impaired in Skeletal Muscle of Diabetic Psammomys Obesus
Protein tyrosine phosphatases (PTPases) have been suggested to modulate the insulin receptor signal transduction pathways.We studied PTPases in Psammomys obesus, an animal model of nutritionally induced insulin resistance. No changes in the protein expression level of src homology PTPase 2 (SHP-2) (muscle, liver) or leukocyte antigen receptor (LAR) (liver) were detected. In contrast, the expression level of PTPase 1B (PTP 1B) in the skeletal muscle, but not in liver, was increased by 83% in the diabetic animals, compared with a diabetes-resistant line. However, PTP 1B– specific activity (activity/protein) significantly decreased (50% to 56%) in skeletal muscle of diabetic animals, compared with both the diabetes-resistant line and diabetes-prone animals. In addition, PTP 1B activity was inversely correlated to serum glucose level (r = –.434, P < .02). These findings suggest that PTP 1B, though overexpressed, is not involved in the susceptibility to insulin resistance in Psammomys obesus and is secondarily attenuated by hyperglycemia or other factors in the diabetic milieu